Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT06807294
Status
Recruiting
Apply to this trial

Conditions

  • Chemotherapy Induced Peripheral Neuropathy (CIPN)
  • Neuropathy
  • Peripheral Neuropathies
  • Peripheral Neuropathy Due to Chemotherapy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tai Chi Program — BEHAVIORAL
    12-week virtual Tai Chi program with experienced Tai Chi instructor. Sessions will be conducted via the HIPPA-compliant teleconference platform, Zoom.

Study Details

This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).

Key Dates

Start date
Jan 16, 2026
Status verified
Jan 2026
Primary completion
Aug 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
21 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Arm A: Tai Chi Treatment Group
    14 randomized participants will complete: * 1 baseline visit session. * Virtual Tai Chi session 2x weekly (60 minutes per session). * Independent Tai Chi sessions 3 days a week (60 minutes per session). * 12 week follow up visit.
  • No Intervention: Arm B: Waitlist Control Group
    7 randomized participants will complete: * 1 baseline visit session * Standard CIPN care prescribed by primary care physician/oncologist. * 12 week follow up visit * Participants will be offered 24 complimentary, virtual, Tai Chi training sessions over 12 weeks after completion of the 12-week follow-up visit.

Primary Outcome Measure

Enrollment Rate for the Tai Chi Program [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dana-Farber Cancer InstituteBostonMassachusetts02215
Ting Bao, MD
[email protected]
857-215-2844
Peter Wayne, PhD
[email protected]
617-732-6271
Ting Bao, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Dana-Farber Cancer Institute· Boston, MA

Related Studies